Effects of Adenoviral Gene Transduction on the Stemness of Human Bone Marrow Mesenchymal Stem Cells |
Marasini, Subash
(Department of Anatomy, Ajou University School of Medicine)
Chang, Da-Young (Department of Anatomy, Ajou University School of Medicine) Jung, Jin-Hwa (Department of Anatomy, Ajou University School of Medicine) Lee, Su-Jung (Department of Anatomy, Ajou University School of Medicine) Cha, Hye Lim (Department of Anatomy, Ajou University School of Medicine) Suh-Kim, Haeyoung (Department of Anatomy, Ajou University School of Medicine) Kim, Sung-Soo (Department of Anatomy, Ajou University School of Medicine) |
1 | Robey, T.E., Saiget, M.K., Reinecke, H., and Murry, C.E. (2008). Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell Cardiol. 45, 567-581. DOI |
2 | Chang, D.Y., Yoo, S.W., Hong, Y., Kim, S., Kim, S.J., Yoon, S.H., Cho, K.G., Paek, S.H., Lee, Y.D., Kim, S.S., et al. (2010). The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. Int. J. Cancer 127, 1975-1983. DOI |
3 | Chen, R.F., and Lee, C.Y. (2014). Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection. Int. Rev. Immunol. 33, 45-53. DOI |
4 | Chen, Y., Shao, J.Z., Xiang, L.X., Dong, X.J., and Zhang, G.R. (2008). Mesenchymal stem cells: a promising candidate in regenerative medicine. Int. J. Biochem. Cell Biol. 40, 815-820. DOI |
5 | Conget, P.A., and Minguell, J.J. (2000). Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp. Hematol. 28, 382-390. DOI |
6 | Crystal, R.G. (1999). In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors. Cancer Chemother. Pharmacol. 43 Suppl, S90-99. DOI |
7 | Deng, Y., Yang, Z., Terry, T., Pan, S., Woodside, D.G., Wang, J., Ruan, K., Willerson, J.T., Dixon, R.A., and Liu, Q. (2016). Prostacyclinproducing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia. Nat. Commun. 7, 11276. DOI |
8 | Deuse, T., Peter, C., Fedak, P.W., Doyle, T., Reichenspurner, H., Zimmermann, W.H., Eschenhagen, T., Stein, W., Wu, J.C., Robbins, R.C., et al. (2009). Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120, S247-254. DOI |
9 | Romieu-Mourez, R., Francois, M., Boivin, M.N., Stagg, J., and Galipeau, J., (2007) Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J. Immunol. 179, 1549-58. DOI |
10 | Suzuki, T., Kawamura, K., Li, Q., Okamoto, S., Tada, Y., Tatsumi, K., Shimada, H., Hiroshima, K., Yamaguchi, N., and Tagawa, M. (2014). Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured. BMC Cancer 14, 713. DOI |
11 | Totsugawa, T., Kobayashi, N., Okitsu, T., Noguchi, H., Watanabe, T., Matsumura, T., Maruyama, M., Fujiwara, T., Sakaguchi, M., and Tanaka, N. (2002). Lentiviral transfer of the LacZ gene into human endothelial cells and human bone marrow mesenchymal stem cells. Cell Transplant 11, 481-488. |
12 | Tsuda, H., Wada, T., Ito, Y., Uchida, H., Dehari, H., Nakamura, K., Sasaki, K., Kobune, M., Yamashita, T., and Hamada, H. (2003). Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol. Ther. 7, 354-365. DOI |
13 | Vorburger, S.A., and Hunt, K.K. (2002). Adenoviral gene therapy. Oncologist 7, 46-59. |
14 | Wang, W.Q., Dong, K., Zhou, L., Jiao, G.H., Zhu, C.Z., Li, W.W., Yu, G., Wu, W.T., Chen, S., Sun, Z.N., et al. (2015). IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice. Acta Pharmacol. Sin 36, 1377-1387. DOI |
15 | www.clinicaltrials.gov (2017). The United States National Institutes of Health Clinical Trial Database. |
16 | Hung, S.C., Lu, C.Y., Shyue, S.K., Liu, H.C., and Ho, L.L. (2004). Lineage differentiation-associated loss of adenoviral susceptibility and Coxsackie-adenovirus receptor expression in human mesenchymal stem cells. Stem Cells 22, 1321-1329. DOI |
17 | Garza-Veloz, I., Romero-Diaz, V.J., Martinez-Fierro, M.L., Marino- Martinez, I.A., Gonzalez-Rodriguez, M., Martinez-Rodriguez, H.G., Espinoza-Juarez, M.A., Bernal-Garza, D.A., Ortiz-Lopez, R., and Rojas-Martinez, A. (2013). Analyses of chondrogenic induction of adipose mesenchymal stem cells by combined co-stimulation mediated by adenoviral gene transfer. Arthritis Res. Ther. 15, R80. DOI |
18 | Gerard, R.D., and Collen, D. (1997). Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis. Cardiovasc. Res. 35, 451-458. DOI |
19 | Haleem-Smith, H., Derfoul, A., Okafor, C., Tuli, R., Olsen, D., Hall, D.J., and Tuan, R.S. (2005). Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol. Biotechnol. 30, 9-20. DOI |
20 | Hocking, A.M., and Gibran, N.S. (2010). Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp. Cell Res. 316, 2213-2219. DOI |
21 | Ju, X.D., Lou, S.Q., Wang, W.G., Peng, J.Q., and Tian, H. (2004). Effect of hydroxyurea and etoposide on transduction of human bone marrow mesenchymal stem and progenitor cell by adeno-associated virus vectors. Acta Pharmacol. Sin. 25, 196-202. |
22 | Kim, M.D., Kim, S.S., Cha, H.Y., Jang, S.H., Chang, D.Y., Kim, W., Suh-Kim, H., and Lee, J.H. (2014). Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. Exp. Mol. Med. 46, e110. DOI |
23 | Larsen, S., and Lewis, I.D. (2011). Potential therapeutic applications of mesenchymal stromal cells. Pathology 43, 592-604. DOI |
24 | Zhang, X.Y., La Russa, V.F., and Reiser, J. (2004). Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J. Virol. 78, 1219-1229. DOI |
25 | Zhang, Y., and Bergelson, J.M. (2005). Adenovirus receptors. J. Virol. 79, 12125-12131. DOI |
26 | Kim, S.S., Choi, J.M., Kim, J.W., Ham, D.S., Ghil, S.H., Kim, M.K., Kim-Kwon, Y., Hong, S.Y., Ahn, S.C., Kim, S.U., et al. (2005). cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. Neuroreport 16, 1357-1361. DOI |
27 | Kim, S.S., Yoo, S.W., Park, T.S., Ahn, S.C., Jeong, H.S., Kim, J.W., Chang, D.Y., Cho, K.G., Kim, S.U., Huh, Y., et al. (2008). Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells 26, 2217-2228. DOI |
28 | Kumar, S., Mahendra, G., Nagy, T.R., and Ponnazhagan, S. (2004). Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy. Hum Gene Ther. 15, 1197-1206. DOI |
29 | Lee, C.I., Kohn, D.B., Ekert, J.E., and Tarantal, A.F. (2004). Morphological analysis and lentiviral transduction of fetal monkey bone marrow-derived mesenchymal stem cells. Mol. Ther. 9, 112-123. |
30 | Lou, J., Xu, F., Merkel, K., and Manske, P. (1999). Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J. Orthop. Res. 17, 43-50. DOI |
31 | Lu, L., Zhao, C., Liu, Y., Sun, X., Duan, C., Ji, M., Zhao, H., Xu, Q., and Yang, H. (2005). Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res Brain Res. Protoc. 15, 46-51. DOI |
32 | Moutsatsos, I.K., Turgeman, G., Zhou, S., Kurkalli, B.G., Pelled, G., Tzur, L., Kelley, P., Stumm, N., Mi, S., Muller, R., et al. (2001). Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3, 449-461. DOI |
33 | McMahon, J.M., Conroy, S., Lyons, M., Greiser, U., O'Shea, C., Strappe, P., Howard, L., Murphy, M., Barry, F., and O'Brien, T. (2006). Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev. 15, 87-96. DOI |
34 | Meirelles Lda, S., Fontes, A.M., Covas, D.T., and Caplan, A.I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419-427. DOI |
35 | Moon, H.H., Joo, M.K., Mok, H., Lee, M., Hwang, K.C., Kim, S.W., Jeong, J.H., Choi, D., and Kim, S.H. (2014). MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine. Biomaterials 35, 1744-1754. DOI |
36 | Musgrave, D.S., Bosch, P., Ghivizzani, S., Robbins, P.D., Evans, C.H., and Huard, J. (1999). Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24, 541-547. DOI |
37 | Park, J.S., Suryaprakash, S., Lao, Y.H., and Leong, K.W. (2015). Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods 84, 3-16. DOI |
38 | Peterson, B., Zhang, J., Iglesias, R., Kabo, M., Hedrick, M., Benhaim, P., and Lieberman, J.R. (2005). Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 11, 120-129. DOI |
39 | Boregowda, S.V., and Phinney, D.G. (2012). Therapeutic applications of mesenchymal stem cells: current outlook. BioDrugs 26, 201-208. DOI |
40 | Ansari, A.M., Ahmed, A.K., Matsangos, A.E., Lay, F., Born, L.J., Marti, G., Harmon, J.W., and Sun, Z. (2016). Cellular GFP toxicity and immunogenicity: potential confounders in in vivo cell tracking experiments. Stem Cell Rev. 12, 553-559. DOI |
41 | Bosch, P., Fouletier-Dilling, C., Olmsted-Davis, E.A., Davis, A.R., and Stice, S.L. (2006). Efficient adenoviral-mediated gene delivery into porcine mesenchymal stem cells. Mol. Reprod. Dev. 73, 1393-1403. DOI |
42 | Breyer, B., Jiang, W., Cheng, H., Zhou, L., Paul, R., Feng, T., and He, T.C. (2001). Adenoviral vector-mediated gene transfer for human gene therapy. Curr. Gene Ther. 1, 149-162. DOI |
43 | Byun, H.M., Suh, D., Jeong, Y., Wee, H.S., Kim, J.M., Kim, W.K., Ko, J.J., Kim, J.S., Lee, Y.B., and Oh, Y.K. (2005). Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells. Biochem. Biophys. Res. Commun. 332, 518-523. DOI |
44 | Chan-Il, C., Young-Don, L., Heejaung, K., Kim, S.H., Suh-Kim, H., and Kim, S.S. (2013). Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model. Cell Transplant. 22, 855-870. DOI |
45 | Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. DOI |
![]() |